Hey everyone. Welcome to the Psychedelics Today podcast. I'm Victoria, your host for today's show,

and we've got a real treat for you today. That's because we're discussing something a lot of you are talking about right now,

microdosing.

It's a topic that we get asked about a lot and a form of psychedelic consumption

that seems to be really attractive to a wide and growing group of people.

It's something that people are seeing pop up

in their social feeds and in the media, and microdosing has begun to feel really approachable

and hopeful for people who just aren't satisfied with the current standard of mental health

care and people who just want to feel better. But they have a lot of questions, and they're trying to do their homework, and wisely

asking what the research is saying.

And if it's really worth it to make microdosing a part of their lives at all, and if there's

enough evidence to back up the stories that they're hearing about improvements in mood

and performance, that subperceptual

doses of LSD and psilocybin can apparently produce.

And luckily, researchers are working to answer these questions, and we've got three of them

on today's show to share what they're finding and what they're trying to find out.

So we are chatting today with Dr. Connor Murray, a UCLA neuroscientist who has published

two papers on the neuroscience of microdosing. Dr. James Fatiman, a world-renowned writer

and researcher known around these parts as the father of modern

microdosing, and Adam Bramledge of flow state micro.

So hopefully this episode will leave you feeling more informed about microdosing.

And if you want to learn more, we've got a great resource in our education center, the microdosing masterclass, which is quickly becoming really popular with folks who want to dive into this topic.

...